Safety, Tolerability, Pharmacokinetics and Efficacy of SPR720 for the Treatment of Patients With Mycobacterium Avium Complex (MAC) Pulmonary Disease
Clinical trial NCT04553406 · TERMINATED
Trial details
- NCT number
- NCT04553406
- Sponsor
- Spero Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-03
- Primary completion
- 2021-01-28
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.